ASHLEY CONDO: Open Payments
NPI 1366682924 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,650 in 88 payments from 23 companies in 2025. Trend: 2023 $1,378 · 2024 $1,672 · 2025 $1,650
Food & beverage: $1,650
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 26 | $497 |
| PFIZER INC. | 10 | $178 |
| Corcept Therapeutics | 5 | $115 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $101 |
| Amgen Inc. | 6 | $96 |
| ABBVIE INC. | 4 | $72 |
| Abbott Laboratories | 3 | $70 |
| Lilly USA, LLC | 4 | $67 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $59 |
Products named: Rybelsus, Ozempic, Wegovy, Korlym, Kerendia, NURTEC ODT, FREESTYLE LIBRE 3, XIFAXAN.
Industry payments across TN — which companies pay providers there.
